PPA
AEGR

Parametric Portfolio Associates’s Aegerion Pharmaceuticals AEGR Stock Holding History

Parametric Portfolio Associates’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,867
Closed -$55K – 3997
2016
Q1 		$55K Buy
+14,867
New +$92.1K ﹤0.01% 3925
2015
Q2 		– Sell
-15,478
Closed -$405K – 4038
2015
Q1 		$405K Sell
15,478
-563
-4% -$14.3K ﹤0.01% 3394
2014
Q4 		$336K Buy
+16,041
New +$404K ﹤0.01% 3486
2014
Q2 		– Sell
-5,348
Closed -$247K – 3853
2014
Q1 		$247K Sell
5,348
-594
-10% -$34.8K ﹤0.01% 3545
2013
Q4 		$422K Buy
5,942
+1,409
+31% +$108K ﹤0.01% 3267
2013
Q3 		$389K Sell
4,533
-1,162
-20% -$98.5K ﹤0.01% 3253
2013
Q2 		$361K Buy
+5,695
New +$302K ﹤0.01% 3191

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Parametric Portfolio Associates's AEGR Position: Q2 2016 in Review

Parametric Portfolio Associates sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 14,867 shares — an estimated $55K sold.

Parametric Portfolio Associates first reported a position in AEGR in Q2 2013 and held it in 7 quarters. The position peaked at $422K in Q4 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • Parametric Portfolio Associates reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14,867 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $55K.
  • Parametric Portfolio Associates first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Parametric Portfolio Associates's Aegerion Pharmaceuticals position peaked at $422K in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Parametric Portfolio Associates's 13F filing for Q2 2016, filed 12 Aug 2016.